Naga Rajiv Lakkaniga

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 7

Top Topics

Rheumatoid Arthritis

Ankylosing Spondylitis

Tyrosine Kinase

Top Venues

Phytotherapy research : PTR

RSC medicinal chemistry

Medicinal research reviews

Journal of medicinal chemistry

This page only lists publications with an associated author ORCID identifier.

Publications

Pallabi Halder, Anubhav Rai, Vishal Talukdar, Parthasarathi Das, Naga Rajiv Lakkaniga
Pyrazolopyridine-based kinase inhibitors for anti-cancer targeted therapy. RSC medicinal chemistry 15 (5) (2024)
Amrita Chatterjee, Monisha Jayaprakasan, Anirban Kr Chakrabarty, Naga Rajiv Lakkaniga, Bibhuti Nath Bhatt, Dipankar Banerjee, Avinash Narwaria, Chandra Kant Katiyar, Sunil Kumar Dubey
Comprehensive insights into rheumatoid arthritis: Pathophysiology, current therapies and herbal alternatives for effective disease management. Phytotherapy research : PTR 38 (6) (2024)
Amrita Chatterjee, Monisha Jayaprakasan, Anirban Kr Chakrabarty, Naga Rajiv Lakkaniga, Bibhuti Nath Bhatt, Dipankar Banerjee, Avinash Narwaria, Chandra Kant Katiyar, Sunil Kumar Dubey
Comprehensive insights into rheumatoid arthritis: Pathophysiology, current therapies and herbal alternatives for effective disease management. Phytotherapy research : PTR 38 (6) (2024)
Amrita Chatterjee, Monisha Jayaprakasan, Anirban Kr Chakrabarty, Naga Rajiv Lakkaniga, Bibhuti Nath Bhatt, Dipankar Banerjee, Avinash Narwaria, Chandra Kant Katiyar, Sunil Kumar Dubey
Comprehensive insights into rheumatoid arthritis: Pathophysiology, current therapies and herbal alternatives for effective disease management. Phytotherapy research : PTR (2024)
Pallabi Halder, Anubhav Rai, Vishal Talukdar, Parthasarathi Das, Naga Rajiv Lakkaniga
Pyrazolopyridine-based kinase inhibitors for anti-cancer targeted therapy. RSC medicinal chemistry 15 (5) (2024)
Naga Rajiv Lakkaniga, Zhengyu Wang, Yao Xiao, Anupreet Kharbanda, Li Lan, Hong-Yu Li
Revisiting Aurora Kinase B: A promising therapeutic target for cancer therapy. Medicinal research reviews (2023)
Marialuisa Moccia, Brendan Frett, Lingtian Zhang, Naga Rajiv Lakkaniga, David C Briggs, Rakhee Chauhan, Annalisa Brescia, Giorgia Federico, Wei Yan, Massimo Santoro, Neil Q McDonald, Hong-Yu Li, Francesca Carlomagno
Bioisosteric Discovery of NPA101.3, a Second-Generation RET/VEGFR2 Inhibitor Optimized for Single-Agent Polypharmacology. Journal of medicinal chemistry 63 (9) (2020)